Risk Prevention Program for Adults With Uncontrolled Epilepsy
Tests a risk prevention session added to patient education in adults with uncontrolled epilepsy.
Key facts
- Who runs it
- University Hospital, Montpellier
- Where
- Montpellier and Toulouse, FranceSee the 2 sites
- Trial code
- Registry title
- Risk Prevention Program and Therapeutic Patient Education Program of Patients With Uncontrolled Epilepsy
- Status
- Recruiting
- People taking part
- 74 people, planned
- Started
- 16 Apr 2024
- Expected to end
- 16 Apr 2028
- Type of study
- Interventional, 2 groups
- Treatments tested
- Risk prevention session
- Usual Therapeutic Patient Education (TPE) management
- Record updated
- 13 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 60 with epilepsy who still have seizures, or who are seizure-free but could benefit from patient education. It tests a risk prevention session added to usual patient education.
- Age
- 18 to 60 years
- Sex
- All sexes can join.
- Disease stage
- Poorly controlled epilepsy (seizures lasting more than a year despite proper treatment), or seizure-free for over a year if the investigator thinks therapeutic patient education (TPE) would help.
- Earlier treatment
- Must not have already taken part in an epilepsy therapeutic patient education (TPE) program.
Main reasons for not taking part
- Already took part in an epilepsy education program (TPE)
- Major cognitive impairment
- Under guardianship or legal protection
- Pregnant or breast-feeding women
- Taking part in another therapeutic research
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Patient between 18 and 60 years old
- Patient with poorly controlled epilepsy (persistence of seizures evolving for more than a year despite proper treatment) or patient seizure-free for over a year but for whom therapeutic patient education (TPE) would be beneficial according to the investigator
- Patient agreeing to participate in a therapeutic education program (TPE)
Who cannot take part
- Epileptic patient who has already benefited from a TPE epilepsy program
- Patients with major cognitive impairment
- Failure to obtain written informed consent after a reflection period
- Patient under guardianship or legal protection (safeguard of justice)
- Pregnant or breast-feeding women
- Patient who for geographical, social or psychological reasons could not participate in the research
- Any situation that, in the opinion of the investigator, could present risks to the patient and to the research
- Participation in another therapeutic research
- Subjects not covered by public health insurance
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
Where in France
- CHU Gui de ChauliacMontpellier, FranceContact: Alice Catheland, NurseTaking people
- CHU de ToulouseToulouse, FranceContact: Marie Denuelle, MDTaking people
About the trial
What the trial wants to find out
Pilot, controled, randomized study aiming to evaluate a plan for the prevention of risks related to epilepsy, 3 months after the last therapeutic patient education session. Two groups of patients will be compared: group "intervention" (consultation with the neurologist then a psychologist followed by a session dedicated to risk prevention ("Recognize and Manage risks") integrated into usual Therapeutic Patient Education (TPE) versus "control" group (usual consultations with the neurologist and usual TPE).
Read full original descriptionShow less
37 subjects per group will be included in this study.
The 2 groups in the trial
- Experimental groupTreatment being tested
Patients of the experimental group will have therapeutic patient education sessions that include one "Recognizing and Managing the Risks of Epilepsy" workshop.
Treatment: Risk prevention session
- Control group "Usual management"Other group
Patients of the "control" group will have the usual therapeutic patient education sessions.
Treatment: Usual Therapeutic Patient Education (TPE) management
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evaluate the Impact of a Specific Risk Prevention Program Associated With a Therapeutic Patient Education Program on the Risk Behaviors of Adult Patients With Uncontrolled Epilepsy.
- Plain-language title
- Risk Prevention Program for Adults With Uncontrolled EpilepsyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06202196, who can take part
- Record updated
- 13 July 2026